Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine.
Saved in:
| Title: | Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine. |
|---|---|
| Authors: | Bresser, Helena1 (AUTHOR), Schmoor, Claudia2 (AUTHOR), Grishina, Olga2 (AUTHOR), Pfeifer, Dietmar1 (AUTHOR), Thomas, Johanna1 (AUTHOR), Rehman, Usama‐Ur1 (AUTHOR), Crysandt, Martina3 (AUTHOR), Jost, Edgar3 (AUTHOR), Thol, Felicitas4 (AUTHOR), Heuser, Michael4 (AUTHOR), Götze, Katharina S.5,6 (AUTHOR), Schlenk, Richard F.7,8 (AUTHOR), Salih, Helmut R.9 (AUTHOR), Schittenhelm, Marcus M.9,10 (AUTHOR), Heil, Gerhard11 (AUTHOR), Schwaenen, Carsten12 (AUTHOR), Müller‐Tidow, Carsten7,13 (AUTHOR), Brugger, Wolfram14 (AUTHOR), Kündgen, Andrea15,16 (AUTHOR), de Wit, Maike17 (AUTHOR) |
| Source: | European Journal of Haematology. Feb2025, Vol. 114 Issue 2, p231-237. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
